-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Life Sciences
-
Healthcare
Life Sciences
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences
Healthcare
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREBLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTS
PODCASTS
"Discover the future through our enlightening podcasts available in the United States.
EXPLORE PODCASTS
White Paper
Access Challenges in the Cancer Patient Journey
Aug 13, 2024
Oncology is rapidly growing in the U.S., with medicine spending increasing by $10 billion to $91 billion from 2022 to 2023. Advances in cancer treatment have led to multiple effective therapy options and extended survival, increasing therapy utilization. However, market competition and higher volumes have prompted payers to increase control and raise access hurdles. This report explores several key points in oncology access:
1. Barriers to Therapy: Access controls are expanding, making it harder for patients to start and maintain therapy.
2. Formulary Exclusions: Since 2021, the use of formulary exclusions in oncology medicines has been rising, affecting both provider- and self-administered treatments.
3. Affordability: Drug prices and financial support are critical issues impacting therapy acquisition.
4. Dispensing Sites: Payer networks often limit patient choices, requiring prescriptions to be filled at specific pharmacies.
5. Medicare Part D Changes: The Inflation Reduction Act's changes to Medicare Part D, including the elimination of 5% patient coinsurance in the Catastrophic phase, may improve affordability but could also lead to greater payer restrictions and "skinny" formularies.
These factors collectively impact patient access to necessary oncology treatments. Read this paper to dive into the details.
1. Barriers to Therapy: Access controls are expanding, making it harder for patients to start and maintain therapy.
2. Formulary Exclusions: Since 2021, the use of formulary exclusions in oncology medicines has been rising, affecting both provider- and self-administered treatments.
3. Affordability: Drug prices and financial support are critical issues impacting therapy acquisition.
4. Dispensing Sites: Payer networks often limit patient choices, requiring prescriptions to be filled at specific pharmacies.
5. Medicare Part D Changes: The Inflation Reduction Act's changes to Medicare Part D, including the elimination of 5% patient coinsurance in the Catastrophic phase, may improve affordability but could also lead to greater payer restrictions and "skinny" formularies.
These factors collectively impact patient access to necessary oncology treatments. Read this paper to dive into the details.